* Alimera Sciences Inc ALIM.OQ ALIM.O is expected
to show a
rise in quarterly revenue when it reports results on August 8
(estimated) for the period ending September 30 2024
* The Alpharetta Georgia-based company is expected to
report a
17.4% increase in revenue to $27.438 million from $23.36 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Alimera Sciences Inc is
for a
loss of 1 cent per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 175.1% in the last three months.
* Wall Street's median 12-month price target for Alimera
Sciences
Inc is $5.50, below its last closing price of $5.55.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -0.06 -0.06 -0.06 Met -63.6
Mar. 31 2024 -0.06 -0.06 -0.12 Missed -111.8
Dec. 31 2023 0.00 -0.07 Missed
Sep. 30 2023 -0.07 -0.06 -0.06 Met 7
Jan. 0.00 0.02 -1.32 Missed -8,900
1 0001
Mar. 31 2023 -0.51 -0.32 -0.71 Missed -121.9
Dec. 31 2022 -0.33 -0.54 Missed -61.2
Sep. 30 2022 -0.40 -0.40 -0.75 Missed -86
This summary was machine generated August 6 at 18:35 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)